As of Sunday, March 16, 2025, here’s an analysis of the Nifty 50 and Bank Nifty indices for the upcoming trading session on Monday, March 17, 2025.

Nifty 50 Analysis:

The Nifty 50 index has been experiencing heightened volatility, influenced by fluctuating global cues. After a sharp 700-point rally over four sessions, the index has been consolidating in a range for the past 4-5 sessions. Immediate support is identified at the 22,200-22,300 levels. Maintaining levels above this support is crucial for a continued pullback towards 22,700 and potentially 23,000 in the upcoming week. Key support zones are further reinforced by the 100-week exponential moving average (EMA) around 22,000 and a rising demand line support near 21,900.

Additionally, the US Dollar Index has declined below the 105-106 levels, forming lower highs and lows on weekly charts, which supports emerging markets like India. Brent crude prices sustaining below the $72-75 mark also present a positive outlook for India’s economy. Furthermore, the US 10-year Treasury yield has dropped to its December low, currently at 4.25%, which is favorable for emerging markets.

Bank Nifty Analysis:

The Bank Nifty index has formed a high wave candle, marking the fifth consecutive week of lower highs and lows. Over the past nine weeks, it has been consolidating within a broad range of 47,800 to 50,500. A close below 47,800 could lead to a decline towards 47,000 in the coming weeks, while holding above this level may result in a pullback towards 49,000.

Market Outlook:

The market is expected to remain range-bound with some volatility and sector rotation, driven by global cues and caution ahead of the US Federal Reserve’s interest rate decision on Wednesday, March 19th.

Stock Recommendations:

For the week starting March 17, 2025, analysts have recommended the following stocks:

1. Piramal Pharma: Buy within the range of ₹193-203, targeting ₹229 over a 12-month period, representing a potential return of 16%. The stock has been forming a base around the long-term 52-week EMA, offering a favorable risk-reward setup.
2. PTC India: Buy within the range of ₹150-157, targeting ₹178 over a 12-month period, also representing a potential return of 16%. The stock has broken out above a three-month range, signaling a resumption of its upward move.

Investors are advised to monitor these support and resistance levels closely and consider the broader economic indicators when making trading decisions.